24
Participants
Start Date
January 17, 2023
Primary Completion Date
August 1, 2027
Study Completion Date
August 1, 2027
Nanosensor
"The purpose of the study is to test a device called a nanosensor, which measures oxygen levels (a proxy of mitochondrial function) in muscle. The nanosensor has not been tested in humans nor has it been approved by the FDA.~The study nanosensor measures 1.8 mm width x 6 mm length x 0.3 mm depth. Placement of the sterilized nanosensor involves a small incision for manual placement of the nanosensor in muscle forearm tissue."
RECRUITING
The Children's Hospital of Philadelphia, Philadelphia
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
Children's Hospital of Philadelphia
OTHER